Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: A case report.
Diagnosing MS: recognizing common symptoms and interpreting MRI results.
Role of TRIF Small Interference RNA (siRNA) in Chronic Experimental Allergic Encephalomyelitis (EAE).
The Potential Roles of Aquaporin 4 in Alzheimer's Disease.
Cucurbitacins attenuate microglial activation and protect from neuroinflammatory injury through Nrf2/ARE activation and STAT/NF-κB inhibition.
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
Serum sickness reaction with skin involvement induced by bee venom injection therapy.
microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.
Lipid rafts and their possible involvements in neuroimmunological disorders.
Social network diversity and white matter microstructural integrity in humans.
[Cormorbidity in multiple sclerosis and its therapeutic approach].
Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.
Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation.
Neurology issues in schizophrenia.
Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report.
Stem cell therapy in multiple sclerosis: a future perspective.
A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
[Cognitive Impairment in Multiple Sclerosis].
Can "dissemination" include the PNS in adults with acute disseminated encephalomyelitis?
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
MS patients must have access to the best treatment options.
How do corticosteroids influence myelin genesis in the central nervous system?
Psychosocial difficulties from the perspective of persons with neuropsychiatric disorders.
Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro.
Osteopontin in Immune-mediated Diseases.
Pages
« first
‹ previous
…
585
586
587
588
589
590
591
592
593
…
next ›
last »